Pharmacokinetics and pharmacodynamics of mavacoxib in the dog

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue SUPPL. 1, 2009, Pages 105-106

  Lees, P ^a   Alexander Bowman, S ^b   Hummel, B ^b   Kubiak, T ^b   Michels, G ^b   Krautmann, M ^b   Cox, S ^b   Toutain, P L ^c   Stegemann, M ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b ZOETIS   (United States)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN; CYCLOOXYGENASE 2 INHIBITOR; MAVACOXIB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; EXPERIMENTAL DOG; IC 50; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SYNOVITIS; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

CANIS FAMILIARIS;

EID: 68149142254     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.01002.x     Document Type: Conference Paper

References (2)

1. Cox, Hummel, et al., J Vet Pharmacol Ther, this issue
2. Cox Liao, et al., J Vet Pharmacol Ther, this issue